The University of Edinburgh

MiChro is an innovative app that empowers users to achieve optimal health. By leveraging cutting-edge principles of chronobiology, MiChro provides personalized recommendations tailored to each user’s health conditions, lifestyle, and goals. Our app integrates advanced data analytics and machine learning to continuously evolve, delivering actionable insights into nutritional status and dietary habits. This ensures users can make sustainable, long-term improvements to their health while enjoying a seamless, engaging experience. Current nutrition apps often fail to deliver the personalization users need. They rely on tedious manual entry, overlook individual restrictions and preferences, and lack interactivity—leading to poor user retention and limited impact. MiChro revolutionizes the nutrition app experience with its intuitive design, personalized features, and dynamic engagement, ensuring every user feels supported on their health journey. Join us in redefining health empowerment through personalized nutrition and advanced technology. Key words: Personalized Nutrition, Chronobiology, HealthTech, AI-powered Health, Nutritional Optimization, Machine Learning for Health, Health Empowerment, Lifestyle Medicine

Lentitek is a biotechnology company focused on developing gene and gene-modified cell therapies, particularly aimed at treating cancer. The company is dedicated to enhancing the accessibility of innovative cures by increasing the yield of lentiviral vectors, which are critical for gene therapy applications. Lentitek employs a proprietary method that utilizes a novel promoter to significantly boost lentiviral production, potentially increasing yields by tenfold or more. This innovative approach not only improves the efficiency of lentivirus production but also aims to reduce overall production costs for healthcare providers, thereby facilitating broader availability of advanced therapeutic options for patients.

The National Biofilms Innovation Centre (NBIC) serves as a collaborative hub uniting academia, industry, government, and public policy to address the challenges posed by biofilms, which significantly impact global economic activity across sectors such as food, health, shipping, clean water, and energy. Supported by funding from the BBSRC, Innovate UK, and Hartree Centre, NBIC's mission focuses on fostering a network for research and innovation that catalyzes partnerships with industry to drive breakthrough innovations. The Centre facilitates the exploration of unmet needs and the exchange of ideas through various initiatives, including roadmaps, workshops, and conferences. Additionally, NBIC is dedicated to nurturing the next generation of scientists through PhD and Post-Doc programs, alongside entrepreneurial training, aimed at enhancing their expertise and understanding of the commercial landscape while promoting the creation of new start-ups.

BioCaptiva is a developer of innovative liquid biopsy technology that focuses on the early diagnosis and monitoring of difficult-to-detect cancers. The company's platform is designed to capture circulating free DNA from patients' blood in larger quantities, addressing the limitations commonly associated with current liquid biopsy testing methods. This advancement enables healthcare professionals to explore new approaches for detecting and monitoring various cancers, ultimately aiming to improve patient outcomes through more effective diagnostics.

Simon Community Scotland is a charitable social firm offering home and support to the homeless people.

Mocean Energy, founded in 2015 and based in Edinburgh, United Kingdom, specializes in developing innovative technologies that harness wave energy to promote a transition to a zero-carbon future. The company focuses on an energy converter that enhances the generation and utilization of electricity from renewable sources. This converter drives a power take-off mechanism that transforms kinetic energy from ocean waves into electricity. As a result, Mocean Energy enables customers to access reliable and affordable renewable energy to power various subsea applications, including control systems, remotely operated vehicles, and autonomous underwater vehicles.

Sphere Fluidics Limited is a life sciences company focused on developing innovative technologies for single-cell analysis and characterization. The company offers specialized cell analysis systems that facilitate the discovery of new cell strains and molecules, aiding scientists in screening for and isolating rare biological variants. Their products serve various applications, including research, therapeutic development, bioproduction, and diagnostics. By providing collaborative research and development services, Sphere Fluidics aims to help clients enhance efficiency, reduce costs, and accelerate advancements in biological and biopharmaceutical discovery.